Charles Chapron (C Chapron)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Positive Breast Cancer

Psychometric Properties

Cross Sectional

Top Venues

Human reproduction (Oxford, England)

Molecular human reproduction

This page only lists publications with an associated author ORCID identifier.

Publications

Charles Chapron, Louis Marcellin, Lorraine Maitrot-Mantelet, Mathilde Bourdon, Chloé Maignien, Guillaume Parpex, Pietro Santulli
Questionnaire-based screening of adolescents and young adult women can identify markers associated with endometriosis. Human reproduction (Oxford, England) (2024)
Charles Chapron, Louis Marcellin, Lorraine Maitrot-Mantelet, Mathilde Bourdon, Chloé Maignien, Guillaume Parpex, Pietro Santulli
Questionnaire-based screening of adolescents and young adult women can identify markers associated with endometriosis. Human reproduction (Oxford, England) 39 (8) (2024)
Jan Hilpert, Esther Groettrup-Wolfers, Hristiyan Kosturski, Laura Bennett, Catriona L K Barnes, Kerstin Gude, Isabella Gashaw, Stefanie Reif, Thomas Steger-Hartmann, Christian Scheerans, Alexander Solms, Antje Rottmann, Guangping Mao, Charles Chapron
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis. Drugs in R&D (2023)
M Bourdon, Pietro Santulli, L Doridot, M Jeljeli, C Chêne, S Chouzenoux, Carole Nicco, L Marcellin, Charles Chapron, F Batteux
Immune cells and Notch1 signaling appear to drive the epithelial to mesenchymal transition in the development of adenomyosis in mice. Molecular human reproduction 27 (10) (2022)
Tina Tellum, Joel Naftalin, Charles Chapron, Margret Dueholm, Sun-Wei Guo, Martin Hirsch, E R Larby, Malcolm G Munro, Ertan Sarıdoğan, Zephne Margeret van der Spuy, Davor Jurkovic
Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study. Human reproduction (Oxford, England) 37 (9) (2022)